Teva Pharmaceuticals

Teva Pharmaceuticals finds
longer-term overhead ceiling,
and a significant buy signal upon settlement above

In this Wicked Signal video-analysis on Teva Pharmaceuticals (TEVA), Cary walks you through the charts to illustrate an overhead price-ceiling able to contain buying into later year, and if settled above, a buy signal that could yield gains of 30% over the following 3-5 months.

Interested in seeing out most recent basic member, video analysis? Click here to view Micron. 

Become a premium member here and receive two or more stock picks a week with educational resources, and more.